{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:24:14Z","timestamp":1791397454018,"version":"4.3.3"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002301","name":"Eesti Teadusagentuur","doi-asserted-by":"publisher","award":["PRG1507"],"award-info":[{"award-number":["PRG1507"]}],"id":[{"id":"10.13039\/501100002301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2019\/35\/N\/ST5\/03882"],"award-info":[{"award-number":["2019\/35\/N\/ST5\/03882"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ejpb.2022.09.008","type":"journal-article","created":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T04:05:29Z","timestamp":1663992329000},"page":"48-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Mucoadhesive brinzolamide-loaded nanofibers for alternative glaucoma treatment"],"prefix":"10.1016","volume":"180","author":[{"given":"Olga","family":"Cegielska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Sierakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4092-9853","authenticated-orcid":false,"given":"Pawe\u0142","family":"Sajkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kairi","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Kogermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2022.09.008_b0005","doi-asserted-by":"crossref","unstructured":"D.-Y. Yu, S.J. Cringle, W.H. Morgan, Glaucoma Related Ocular Structure and Function, in: X, Sun, Y. Dai (Eds.), Medical Treatment of Glaucoma, Springer Nature Singapore Pte Ltd., Singapore, 2019, pp. 2, DOI: 10.1007\/978-981-13-2733-9.","DOI":"10.1007\/978-981-13-2733-9"},{"key":"10.1016\/j.ejpb.2022.09.008_b0010","unstructured":"N. Mahabadi, L.A. Foris, K. Tripathy, Open Angle Glaucoma. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK441887\/#article-22264.s1 (accessed 2022-01-21)."},{"key":"10.1016\/j.ejpb.2022.09.008_b0015","doi-asserted-by":"crossref","unstructured":"A.C. Momont, P.L. Kaufman, Medical Therapy for Glaucoma-IOP Lowering Agents, in: X, Sun, Y. Dai (Eds.), Medical Treatment of Glaucoma, Springer Nature Singapore Pte Ltd., Singapore, 2019, pp. 122-124, DOI: 10.1007\/978-981-13-2733-9.","DOI":"10.1007\/978-981-13-2733-9_5"},{"key":"10.1016\/j.ejpb.2022.09.008_b0020","doi-asserted-by":"crossref","unstructured":"B. Plazonnet, Ophthalmic drug delivery, in: M.J. Rathbone, J. Hadgraft, M.S. Roberts (Eds.), Modified-Release Drug Delivery Technology, Marcel Dekker, New York, USA, 2003, pp. 290-292, DOI: 10.1201\/9780203910337.","DOI":"10.1201\/9780203910337.pt3"},{"key":"10.1016\/j.ejpb.2022.09.008_b0025","doi-asserted-by":"crossref","unstructured":"R. Jani, E. Rhone, Ion Exchange Resin Technology for Ophthalmic Applications, in: M.J. Rathbone, J. Hadgraft, M.S. Roberts (Eds.), Modified-Release Drug Delivery Technology, Marcel Dekker, New York, USA, 2003, p. 315, doi:10.1201\/9780203910337.","DOI":"10.1201\/9780203910337.ch26"},{"key":"10.1016\/j.ejpb.2022.09.008_b0030","doi-asserted-by":"crossref","unstructured":"Y. Chen, K. Jiang, G. Wei, Y. Dai, Medical Treatment Strategy for Glaucoma, in: X, Sun, Y. Dai (Eds.), Medical Treatment of Glaucoma, Springer Nature Singapore Pte Ltd., Singapore, 2019, pp. 99-101, DOI: 10.1007\/978-981-13-2733-9.","DOI":"10.1007\/978-981-13-2733-9_4"},{"issue":"4","key":"10.1016\/j.ejpb.2022.09.008_b0035","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2165\/00002512-200623040-00005","article-title":"Glaucoma medications: use and safety in the elderly population","volume":"23","author":"Kanner","year":"2006","journal-title":"Drugs & Aging"},{"issue":"7","key":"10.1016\/j.ejpb.2022.09.008_b0040","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1208\/s12249-017-0710-8","article-title":"PLGA nanoparticles as subconjunctival injection for management of glaucoma","volume":"18","author":"Salama","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2022.09.008_b0045","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.exer.2014.06.013","article-title":"28-day intraocular pressure reduction with a single dose of brimonidine tartrate-loaded microspheres","volume":"125","author":"Fedorchak","year":"2014","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejpb.2022.09.008_b0050","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.2147\/OPTH.S24358","article-title":"Evaluation of patients\u2019 experiences at different stages of the intravitreal injection procedure \u2013 what can be improved?","volume":"5","author":"Tailor","year":"2011","journal-title":"Clin. Ophthalmol."},{"issue":"3","key":"10.1016\/j.ejpb.2022.09.008_b0055","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1208\/s12249-013-9997-2","article-title":"Ophthalmic delivery of brinzolamide by liquid crystalline nanoparticles, in vitro and in vivo evaluation","volume":"14","author":"Wu","year":"2013","journal-title":"AAPS PharmSciTech"},{"issue":"91","key":"10.1016\/j.ejpb.2022.09.008_b0060","article-title":"Nanoliposome-encapsulated brinzolamide-hydropropyl-\u03b2-cyclodextrin Inclusion complex: a potential therapeutic ocular drug-delivery system","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejpb.2022.09.008_b0065","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s13346-019-00697-0","article-title":"Design, optimisation and evaluation of in situ gelling nanoemulsion formulations of brinzolamide","volume":"10","author":"Bhalerao","year":"2020","journal-title":"Drug Delivery Transl. Res."},{"key":"10.1016\/j.ejpb.2022.09.008_b0070","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.ijbiomac.2019.10.219","article-title":"Brinzolamide loaded chitosan-pectin mucoadhesive nanocapsules for management of glaucoma: Formulation, characterization and pharmacodynamic study","volume":"152","author":"Dubey","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"15","key":"10.1016\/j.ejpb.2022.09.008_b0075","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.3390\/app10155151","article-title":"Contact lenses as drug delivery system for glaucoma: a review","volume":"10","author":"Peral","year":"2020","journal-title":"Appl. Sci."},{"issue":"4","key":"10.1016\/j.ejpb.2022.09.008_b0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095461","article-title":"Bimatoprost-loaded ocular inserts as sustained release drug delivery systems for glaucoma treatment. In vitro and in vivo evaluation","volume":"9","author":"Franca","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ejpb.2022.09.008_b0085","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s13346-011-0018-2","article-title":"Sustained release ocular inserts of brimonidine tartrate for better treatment in open-angle glaucoma","volume":"1","author":"Bhagav","year":"2011","journal-title":"Drug Delivery Transl. Res."},{"key":"10.1016\/j.ejpb.2022.09.008_b0090","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jconrel.2012.06.017","article-title":"Extended drug delivery by contact lenses for glaucoma therapy","volume":"162","author":"Peng","year":"2012","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ejpb.2022.09.008_b0095","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.biomaterials.2013.09.032","article-title":"In vivo performance of a drug-eluting contact lens to treat glaucoma","volume":"35","author":"Ciolino","year":"2014","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.ejpb.2022.09.008_b0100","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1021\/acsbiomaterials.7b00706","article-title":"Self-assembling peptide nanofiber hydrogels for controlled ocular delivery of timolol maleate","volume":"3","author":"Karavasili","year":"2017","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.ejpb.2022.09.008_b0105","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejps.2013.11.016","article-title":"Goyal, Development and characterization of nano-fiber patch for the treatment of glaucoma","volume":"53","author":"Gagandeep","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ejpb.2022.09.008_b0110","first-page":"669","article-title":"Preparation and in vivo evaluation of sodium alginate - poly (vinyl alcohol) electrospun nanofibers of forskolin for glaucoma treatment","volume":"32","author":"Yellanki","year":"2019","journal-title":"Pak. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2022.09.008_b0115","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.3390\/pharmaceutics13101637","article-title":"A systematic review of drug-loaded electrospun nanofiber-based ophthalmic inserts","volume":"13","author":"Omer","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2022.09.008_b0120","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jconrel.2021.03.033","article-title":"Electrospinning for drug delivery applications: a review","volume":"334","author":"Luraghi","year":"2021","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ejpb.2022.09.008_b0125","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejpb.2019.11.012","article-title":"Electrospun nanofibers \u2013 a promising solid in-situ gelling alternative for ocular drug delivery","volume":"146","author":"G\u00f6ttel","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"12","key":"10.1016\/j.ejpb.2022.09.008_b0130","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.progpolymsci.2014.07.010","article-title":"Mucoadhesive polymers in the design of nano-drug delivery systems for administration by non-parenteral routes: a review","volume":"39","author":"Sosnik","year":"2014","journal-title":"Prog. Polym. Sci."},{"issue":"8","key":"10.1016\/j.ejpb.2022.09.008_b0135","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.1021\/acs.chemrev.8b00593","article-title":"Electrospinning and electrospun nanofibers: methods, materials, and applications","volume":"119","author":"Xue","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejpb.2022.09.008_b0140","doi-asserted-by":"crossref","first-page":"120955","DOI":"10.1016\/j.ijpharm.2021.120955","article-title":"Cyclodextrin-based formulation of carbonic anhydrase inhibitors for ocular delivery \u2013 a review","volume":"606","author":"Jansook","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.09.008_b0145","series-title":"Innovative Dosage Forms: Design and Development at Early Stage","first-page":"331","article-title":"Design and Development of Ocular Formulations for Preclinical and Clinical Trials","author":"Schmitt","year":"2019"},{"key":"10.1016\/j.ejpb.2022.09.008_b0150","first-page":"14245","article-title":"1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP) as a novel and effective solvent to facilely prepare cyclodextrin-assembled materials","volume":"50","author":"Kida","year":"2014","journal-title":"ChemComm"},{"issue":"2","key":"10.1016\/j.ejpb.2022.09.008_b0155","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3390\/molecules22020230","article-title":"Electrospun fibers of cyclodextrins and poly(cyclodextrins)","volume":"22","author":"Costoya","year":"2017","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.ejpb.2022.09.008_b0160","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3144\/expresspolymlett.2008.90","article-title":"Pharmaceutical significance of cellulose: a review","volume":"2","author":"Kamel","year":"2008","journal-title":"Express Polym. Lett."},{"issue":"4","key":"10.1016\/j.ejpb.2022.09.008_b0165","doi-asserted-by":"crossref","DOI":"10.3390\/nano10040754","article-title":"Preparation and evaluation of nanofibrous hydroxypropyl cellulose and \u03b2-cyclodextrin polyurethane composite mats","volume":"10","author":"Gradinaru","year":"2020","journal-title":"Nanomaterials"},{"issue":"2","key":"10.1016\/j.ejpb.2022.09.008_b0170","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1166\/jnn.2018.13852","article-title":"Green electrospining of hydroxypropyl cellulose nanofibres for drug delivery applications","volume":"18","author":"El-Newehy","year":"2018","journal-title":"J Nanosci Nanotechnol"},{"key":"10.1016\/j.ejpb.2022.09.008_b0175","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4028\/www.scientific.net\/KEM.859.239","article-title":"Development of electrospun shellac and hydroxypropyl cellulose blended nanofibers for drug carrier application","volume":"859","author":"Chinatangkul","year":"2020","journal-title":"Key Eng. Mater."},{"key":"10.1016\/j.ejpb.2022.09.008_b0180","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.progpolymsci.2010.04.002","article-title":"The return of a forgotten polymer\u2014Polycaprolactone in the 21st century","volume":"35","author":"Woodruff","year":"2010","journal-title":"Prog. Polym. Sci."},{"issue":"7","key":"10.1016\/j.ejpb.2022.09.008_b0185","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1080\/00914037.2014.945208","article-title":"Electrospinning and structure of bicomponent polycaprolactone\/gelatin nanofibers obtained using alternative solvent system","volume":"64","author":"Denis","year":"2015","journal-title":"Int. J. Polym. Mater. Polym. Biomater."},{"key":"10.1016\/j.ejpb.2022.09.008_b0190","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.eurpolymj.2015.01.028","article-title":"Porous electrospun polycaprolactone (PCL) fibres by phase separation","volume":"69","author":"Katsogiannis","year":"2015","journal-title":"Eur. Polym. J."},{"issue":"2","key":"10.1016\/j.ejpb.2022.09.008_b0195","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1517\/17425247.2.1.335","article-title":"Cyclodextrins in drug delivery (Review)","volume":"2","author":"Loftsson","year":"2005","journal-title":"Expert Opin. Drug Delivery"},{"issue":"12","key":"10.1016\/j.ejpb.2022.09.008_b0200","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1080\/02713683.2018.1510970","article-title":"The sheep cornea: structural and clinical characteristics","volume":"43","author":"Greene","year":"2018","journal-title":"Current Eye Research"},{"key":"10.1016\/j.ejpb.2022.09.008_b0205","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1364\/JOSAA.36.001015","article-title":"Characterization of the ocular surface temperature dynamics in glaucoma subjects using long-wave infrared thermal imaging","volume":"36","author":"Garc\u00eda-Porta","year":"2019","journal-title":"J. Opt. Soc. Am. A"},{"key":"10.1016\/j.ejpb.2022.09.008_b0210","unstructured":"CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Eight Informational Supplement (M100-S28); Clinical and Laboratory Standards Institute: Wayne, PA, USA or ISO 20776-1:2019."},{"key":"10.1016\/j.ejpb.2022.09.008_b0215","doi-asserted-by":"crossref","first-page":"119761","DOI":"10.1016\/j.ijpharm.2020.119761","article-title":"In vitro physicochemical characterization and dissolution of brinzolamide ophthalmic suspensions with similar composition","volume":"588","author":"Vo","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.ejpb.2022.09.008_b0220","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1208\/s12249-013-0023-5","article-title":"Molecular inclusion complex of curcumin-\u03b2-cyclodextrin nanoparticle to enhance curcumin skin permeability from hydrophilic matrix gel","volume":"14","author":"Rachmawati","year":"2013","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2022.09.008_b0225","doi-asserted-by":"crossref","first-page":"118079","DOI":"10.1016\/j.carbpol.2021.118079","article-title":"Structure-property relationships on recrystallized \u03b2-cyclodextrin solvates: a focus on X-ray diffractometry, FTIR and thermal analyses","volume":"265","author":"Medeleanu","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejpb.2022.09.008_b0230","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.molstruc.2007.11.062","article-title":"Structure of hexafluoroisopropanol\u2013water mixture studied by FTIR-ATR spectra and selected chemometric methods","volume":"883\u2013884","author":"Czarnik-Matusewicz","year":"2008","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejpb.2022.09.008_b0235","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s00289-020-03202-7","article-title":"Design and preparation of UV-curable waterborne polyurethane based on novel fuorinated chain extender","volume":"78","author":"Shan","year":"2021","journal-title":"Polym. Bull."},{"key":"10.1016\/j.ejpb.2022.09.008_b0240","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.1021\/jp101888g","article-title":"Temperature effect on the vibrational dynamics of cyclodextrin inclusion complexes: investigation by FTIR-ATR spectroscopy and numerical simulation","volume":"114","author":"Crupi","year":"2010","journal-title":"J. Phys. Chem. A"},{"issue":"2\u20133","key":"10.1016\/j.ejpb.2022.09.008_b0245","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.colsurfa.2006.06.023","article-title":"Complex formation of ionic liquid surfactant and \u03b2-cyclodextrin","volume":"292","author":"Li","year":"2007","journal-title":"Colloids Surf. A: Physicochem. Eng. Asp."},{"key":"10.1016\/j.ejpb.2022.09.008_b0250","series-title":"Encapsulations. Nanotechnology in the Agri-Food Industry","first-page":"769","article-title":"Nanoencapsulation of flavors and aromas by cyclodextrins","author":"Fenyvesi","year":"2016"},{"issue":"7","key":"10.1016\/j.ejpb.2022.09.008_b0255","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.addr.2007.05.012","article-title":"Cyclodextrins as pharmaceutical solubilizers","volume":"59","author":"Brewster","year":"2007","journal-title":"Adv. Drug Delivery Rev."},{"key":"10.1016\/j.ejpb.2022.09.008_b0260","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ejpb.2010.07.005","article-title":"Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: formulation of dorzolamide eye drop microparticle suspension","volume":"76","author":"Jansook","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2022.09.008_b0265","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/eye.2012.25","article-title":"Free radicals and the pH of topical glaucoma medications: a lifetime of ocular chemical injury?","volume":"26","author":"Lockington","year":"2012","journal-title":"Eye"},{"issue":"4","key":"10.1016\/j.ejpb.2022.09.008_b0270","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/scipharm87040033","article-title":"Cyclodextrins in drug delivery systems and their effects on biological barriers","volume":"87","author":"Haimhoffer","year":"2019","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.ejpb.2022.09.008_b0275","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1755-3768.2011.02299.x","article-title":"Topical drug delivery to the eye: Dorzolamide","volume":"90","author":"Loftsson","year":"2012","journal-title":"Acta Ophthalmol."},{"issue":"5","key":"10.1016\/j.ejpb.2022.09.008_b0280","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s13233-014-2078-x","article-title":"Preparation and characterization of hybrid polycaprolactone\/cellulose ultrafine fibers via electrospinning","volume":"22","author":"Ali","year":"2014","journal-title":"Macromol. Res."},{"key":"10.1016\/j.ejpb.2022.09.008_b0285","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s10973-015-5047-5","article-title":"The kinetics of crystallization of poly(\u03b5-caprolactone) measured by FTIR spectroscopy","volume":"123","author":"Phillipson","year":"2016","journal-title":"J. Therm. Anal. Calorim."},{"key":"10.1016\/j.ejpb.2022.09.008_b0290","doi-asserted-by":"crossref","first-page":"102637","DOI":"10.1016\/j.rinp.2019.102637","article-title":"Macrostructure and optical studies of hydroxypropyl cellulose in pure and Nano-composites forms","volume":"15","author":"Alharbi","year":"2019","journal-title":"Results Phys."},{"issue":"4","key":"10.1016\/j.ejpb.2022.09.008_b0295","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4103\/2230-973X.143131","article-title":"Design, formulation, and evaluation of novel sustain release bioadhesive in-situ gelling ocular inserts of ketorolac tromethamine","volume":"4","author":"Jethava","year":"2014","journal-title":"Int. J. Pharm. Invest."},{"issue":"1","key":"10.1016\/j.ejpb.2022.09.008_b0300","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/10837450.2021.2018609","article-title":"Preparation and functional evaluation of electrospun polymeric nanofibers as a new system for sustained topical ocular delivery of itraconazole","volume":"27","author":"Mehrandish","year":"2022","journal-title":"Pharm. Dev. Technol."},{"issue":"12","key":"10.1016\/j.ejpb.2022.09.008_b0305","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3390\/pharmaceutics12121158","article-title":"Curcumin in situ gelling polymeric insert with enhanced ocular performance","volume":"12","author":"Abdelkader","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2022.09.008_b0310","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijpharm.2019.05.059","article-title":"Development and evaluation of performance characteristics of timolol-loaded composite ocular films as potential delivery platforms for treatment of glaucoma","volume":"566","author":"Tighsazzadeh","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2022.09.008_b0315","first-page":"207","article-title":"Preparation and Evaluation of bioadhesive ocular inserts of aceclofenac","volume":"41","author":"Kalyanwat","year":"2016","journal-title":"Int. J. Pharm. Sci. Rev. Res."},{"key":"10.1016\/j.ejpb.2022.09.008_b0320","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.1039\/b719709h","article-title":"Mechanical properties of composite polymer microstructures fabricated by interference lithography","volume":"10","author":"Singamaneni","year":"2008","journal-title":"Phys. Chem. Chem. Phys."},{"issue":"22","key":"10.1016\/j.ejpb.2022.09.008_b0325","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1063\/1.1579125","article-title":"Failure modes of electrospun nanofibers","volume":"82","author":"Zussman","year":"2003","journal-title":"Appl. Phys. Lett."},{"key":"10.1016\/j.ejpb.2022.09.008_b0330","first-page":"587","article-title":"Review of hydroxypropyl cellulose ophthalmic inserts for treatment of dry eye","volume":"5","author":"Nguyen","year":"2011","journal-title":"Clin. Ophthalmol."},{"issue":"05","key":"10.1016\/j.ejpb.2022.09.008_b0335","first-page":"195","article-title":"Mucoadhesive polymers and their mode of action: a recent update","volume":"7","author":"Chatterjee","year":"2017","journal-title":"J. Appl. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2022.09.008_b0340","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jconrel.2021.06.011","article-title":"Ocular drug delivery to the anterior segment using nanocarriers: a mucoadhesive\/mucopenetrative perspective","volume":"336","author":"Dave","year":"2021","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ejpb.2022.09.008_b0345","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.colsurfb.2016.08.048","article-title":"Improving the topical ocular pharmacokinetics of animmunosuppressant agent with mucoadhesive nanoemulsions: Formulation development, in vitro and in vivo studies","volume":"148","author":"Akhter","year":"2016","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"4","key":"10.1016\/j.ejpb.2022.09.008_b0350","doi-asserted-by":"crossref","DOI":"10.3390\/nano10040709","article-title":"In vitro and ex vivo evaluation of nepafenac-based cyclodextrin microparticles for treatment of eye inflammation","volume":"10","author":"Lorenzo-Veiga","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.ejpb.2022.09.008_b0355","doi-asserted-by":"crossref","first-page":"116428","DOI":"10.1016\/j.carbpol.2020.116428","article-title":"Swelling of mucoadhesive electrospun chitosan\/polyethylene oxide nanofibers facilitates adhesion to the sublingual mucosa","volume":"242","author":"Stie","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejpb.2022.09.008_b0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/924947","article-title":"A mucoadhesive electrospun nanofibrous matrix for rapid oramucosal drug delivery","volume":"2013","author":"Dott","year":"2013","journal-title":"J. Nanomater."},{"key":"10.1016\/j.ejpb.2022.09.008_b0365","doi-asserted-by":"crossref","first-page":"13381","DOI":"10.1021\/acsami.8b03329","article-title":"Mucoadhesion of progesterone-loaded drug delivery nanofiber constructs","volume":"10","author":"Brako","year":"2010","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejpb.2022.09.008_b0370","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.2147\/IJN.S193328","article-title":"Mucoadhesive electrospun nanofibers for drug delivery systems: applications of polymers and the parameters' roles","volume":"14","author":"P\u00e9rez-Gonz\u00e1lez","year":"2019","journal-title":"Int. J. Nanomed."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2022.09.008_b0375","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ijpharm.2017.06.075","article-title":"Enhancement and inhibition effects on the corneal permeability of timolol maleate: polymers, cyclodextrins and chelating agents","volume":"529","author":"Rodriguez","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.09.008_b0380","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.eurpolymj.2016.07.016","article-title":"Impact of sterilization methods on electrospun scaffolds for tissue engineering","volume":"82","author":"Rediguieri","year":"2016","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.ejpb.2022.09.008_b0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118450","article-title":"Effects and efficacy of different sterilization and disinfection methods on electrospun drug delivery systems","volume":"567","author":"Preem","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.09.008_b0390","doi-asserted-by":"crossref","first-page":"100804","DOI":"10.1016\/j.preteyeres.2019.100804","article-title":"Contact lens-related corneal infection: intrinsic resistance and its compromise","volume":"76","author":"Fleiszig","year":"2020","journal-title":"Prog. Retinal Eye Res."},{"issue":"4","key":"10.1016\/j.ejpb.2022.09.008_b0395","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1089\/ham.2010.1051","article-title":"Acetazolamide and sulfonamide allergy: a not so simple story","volume":"11","author":"Kelly","year":"2010","journal-title":"High Alt. Med. Biol."},{"issue":"9","key":"10.1016\/j.ejpb.2022.09.008_b0400","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1021\/jm9003126","article-title":"Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new \u03b2-carbonic anhydrase from mycobacterium tuberculosis","volume":"52","author":"Nishimori","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejpb.2022.09.008_b0405","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.11059","article-title":"In vitro and in vivo activities of the carbonic anhydrase inhibitor, dorzolamide, against vancomycin-resistant enterococci","volume":"9","author":"Abutaleb","year":"2021","journal-title":"PeerJ"},{"issue":"3","key":"10.1016\/j.ejpb.2022.09.008_b0410","doi-asserted-by":"crossref","DOI":"10.18773\/austprescr.2018.016","article-title":"Common eye infections","volume":"41","author":"Watson","year":"2018","journal-title":"Aust. Prescr."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964112200203X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964112200203X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:49:12Z","timestamp":1760546952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093964112200203X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":82,"alternative-id":["S093964112200203X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2022.09.008","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mucoadhesive brinzolamide-loaded nanofibers for alternative glaucoma treatment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2022.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}